[REVISION HISTORY]
Global spread and monitoring of COVID-19 PJ.2.1 variant
5 recorded revisions of this situation.
What changed
2026-11-18 03:14 UTC → 2026-11-19 20:41 UTC ·
added
removed
The PJ.2.1 variant of the coronavirus, referred to by Chinese researchers as “The Leap”, continues to spread globally. Originally identified in Ontario, Canada, on May 2, 2026, the variant has been detected in several Canadian provinces, various U.S. states, Spain, France, Israel, Singapore, Australia, and New Zealand. Zealand, and Brazil. Characterized by numerous mutations in the spike protein, laboratory findings suggest the variant may bind more effectively to the ACE2 receptor, potentially increasing its ability to enter human cells. This finding was supported by a study Research published in the Journal of Infection on October 24, which noted the lineage exhibits News Medical Life Sciences indicates this higher efficiency in binding affinity may allow the variant to penetrate human cells, potentially facilitating rapid spread. cells more effectively, contributing to a potential for faster transmission. While current vaccines remain effective, experts such as Markus Hoffmann from the German Primate Center warn that further mutations could eventually allow the virus to evade existing immune responses. In response to the variant's spread, the World Health Organization (WHO) has added PJ.2.1 to its list of lineages under evaluation to inform future vaccine updates. This follows a data request issued on October 27, ahead of a December committee meeting to determine necessary adjustments to immunizations. While experts like Gennady Onishchenko and Elena Malnikova have noted that primary symptoms include severe throat pain, fatigue, such as fever, cough, sore throat, headache, and muscle aches, there aches closely resemble the common cold or seasonal influenza, health officials emphasize that diagnostic testing is essential to distinguish the variant from other respiratory infections. There is currently no convincing evidence that PJ.2.1 causes more severe illness illness, higher hospitalization rates, or higher mortality than previous variants. However, the Brazilian Ministry of Health has reported an upward trend in respiratory syndrome notifications associated with Covid-19, with 118,920 notifications recorded in Brazil as of early November 2026. Despite the rising cases in certain regions, scientific assessments suggest it is unlikely to trigger a new pandemic. Vulnerable vulnerable populations, particularly seniors aged 60 and older, those with chronic health conditions, remain at the highest risk.
Versions
- 2026-11-19 20:41 UTC Global spread and monitoring of COVID-19 PJ.2.1 variant
- 2026-11-18 03:14 UTC Global spread and monitoring of COVID-19 PJ.2.1 variant
- 2026-11-12 05:00 UTC Global spread of COVID-19 PJ.2.1 variant
- 2026-11-11 16:07 UTC Global spread of COVID-19 PJ.2.1 variant
- 2026-11-11 05:34 UTC Global spread of COVID-19 PJ.2.1 variant
- 2026-11-08 09:04 UTC COVID-19 PJ.2.1 variant emergence
Select a version to see what changed compared to the one before it.